After achieving her PhD in Chemistry at The University of Milan (Italy) in 2008 followed by her post-doctoral research training in the cross-disciplinary field of applied nanotechnology in the UK and Ireland Dr Krpetic joined the University of Salford, Manchester as a Lecturer in Physical Chemistry in September 2016, where she will be teaching Physical and Analytical Chemistry to(Level 5) BSc (Hons) Medicinal Chemistry students.
Dr Krpetic previously worked in several academic institutions across UK and Europe Centre for BioNano Interactions (CBNI), University College Dublin (Ireland), The University of Liverpool (UK) and Stratchlyde University (UK) where she took an active role in several European, UK and Irish research projects: FP6 “NACARDIO”, EU FP7 “BisNano”, EPSRC funded “Science an
more...After achieving her PhD in Chemistry at The University of Milan (Italy) in 2008 followed by her post-doctoral research training in the cross-disciplinary field of applied nanotechnology in the UK and Ireland Dr Krpetic joined the University of Salford, Manchester as a Lecturer in Physical Chemistry in September 2016, where she will be teaching Physical and Analytical Chemistry to(Level 5) BSc (Hons) Medicinal Chemistry students.
Dr Krpetic previously worked in several academic institutions across UK and Europe Centre for BioNano Interactions (CBNI), University College Dublin (Ireland), The University of Liverpool (UK) and Stratchlyde University (UK) where she took an active role in several European, UK and Irish research projects: FP6 “NACARDIO”, EU FP7 “BisNano”, EPSRC funded “Science and Innovation” (UK), EU FP7 ‘FutureNanoNeeds’, EU FP7 ‘NanoSolutions, Collaborative Centre for Applied Nanotechnology - CCAN ‘Nanokinetics’ project and FP7 ‘NanoMILE’.
As a result of her broader research engagement Dr Krpetic is a member of the editorial board of Cancer Nanotechnology journal (Springer Publishing group) since 2014.
Dr Krpetic is an expert in preparative nano chemistry and tailored functionalisation of nanoparticles for diverse range of biomedical applications including development multimodal sensing platforms, synthesis of nanoparticles for targeted delivery and cancer therapy and development of new approaches to nanoparticle characterisation.
Amongst many achievements, Dr Krpetic designed novel nanoparticle systems applied in multimodal nanoparticle-based sensing; she designed and manufactured the first example of gold nanoparticle based tool for ultra-sensitive double stranded DNA detection; she developed novel nanoparticles cell uptake studies and investigation of the intracellular fate and developed gold nanoparticles and new approaches for circumventing cell particle uptake by endocytosis-based mechanisms, that is of vital importance for the future use of nano particles in nanomedicine and drug delivery and she created highly monodisperse gold anisotropic nanoparticle libraries and developed protocols for new clean approaches to nanoparticle syntheses for in vivo and in vitro applications.